Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver

Effects of Excessive Fructose Intake on Health

(2013) Richard J. Johnson et al.   ANNALS OF INTERNAL MEDICINE

AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice

(2011) Yu Li et al.   Cell Metabolism

The Emerging Role of Endocrine Disruptors in Pathogenesis of Insulin Resistance: A Concept Implicating Nonalcoholic Fatty Liver Disease

(2011) S. A. Polyzos et al.   CURRENT MOLECULAR MEDICINE

Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes

(2011) A. I. Schmid et al.   DIABETES CARE

The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation

(2011) Emma Barroso et al.   ENDOCRINOLOGY

Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver

(2011) Eun-Jeong Jung et al.   JOURNAL OF LIPID RESEARCH

Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake

(2011) Carlos A. Roncal-Jimenez et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease

(2010) Giovanni Musso et al.   Annual Review of Medicine

AMPK Activators as Novel Therapeutics for Type 2 Diabetes

(2010) Li-Fang Yu et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Metformin Activates AMP Kinase through Inhibition of AMP Deaminase

(2010) Jiangyong Ouyang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mechanisms Linking Obesity, Chronic Kidney Disease, and Fatty Liver Disease: The Roles of Fetuin-A, Adiponectin, and AMPK

(2010) J. H. Ix et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Proteomics analysis of cardiac muscle from rats with peroxisomal proliferator-activated receptor α (PPARα) stimulation

(2010) Masafumi Miyazaki et al.   JOURNAL OF TOXICOLOGICAL SCIENCES

High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study

(2010) Chengfu Xu et al.   PLoS One

Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study

(2009) Llorenç Caballería et al.   BMC GASTROENTEROLOGY

Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance

(2009) Kimber L Stanhope et al.   CURRENT OPINION IN LIPIDOLOGY

Association Between Serum Uric Acid and Development of Type 2 Diabetes

(2009) S. Kodama et al.   DIABETES CARE

Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver

(2009) Laura G. Sánchez-Lozada et al.   EUROPEAN JOURNAL OF NUTRITION

ZAC1 Is Up-regulated by Hypertonicity and Decreases Sorbitol Dehydrogenase Expression, Allowing Accumulation of Sorbitol in Kidney Cells

(2009) Miguel A. Lanaspa et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

(2008) Xiaosen Ouyang et al.   JOURNAL OF HEPATOLOGY